-
Microwave vs radiofrequency ablation for small renal masses: perioperative and oncological outcomes BJU Int. (IF 3.7) Pub Date : 2024-09-18 Letizia Maria Ippolita Jannello, Franco Orsi, Stefano Luzzago, Giovanni Mauri, Francesco A. Mistretta, Mattia Luca Piccinelli, Chiara Vaccaro, Marco Tozzi, Daniele Maiettini, Gianluca Varano, Stefano Caramella, Paolo Della Vigna, Matteo Ferro, Guido Bonomo, Zhe Tian, Pierre I. Karakiewicz, Ottavio De Cobelli, Gennaro Musi
To conduct a comprehensive comparison of microwave ablation (MWA) vs radiofrequency ablation (RFA) outcomes in the treatment of small renal masses (SRMs), specifically: TRIFECTA ([i] complete ablation, [ii] absence of Clavien–Dindo Grade ≥III complications, and [iii] absence of ≥30% decrease in estimated glomerular filtration rate) achievement, operative time (OT), and local recurrence rate (LRR).
-
Re: quality‐of‐life outcomes of the ROBOtic‐assisted vs conventional open partial nephrectomy (ROBOCOP) II trial BJU Int. (IF 3.7) Pub Date : 2024-09-13 Mithilesh Yadav, Sambit Tripathy, Kirti Singh, Swarnendu Mandal, Manoj Kumar Das, Kalandi Barik, Prasant Nayak
-
Differences in mutations across tumour sizes in clear‐cell renal cell carcinoma BJU Int. (IF 3.7) Pub Date : 2024-09-12 Steven M. Monda, Benjamin W. Carney, Allison M. May, Shuchi Gulati, Simpa S. Salami, Thenappan Chandrasekar, Evan T. Keller, Nicolai A. Huebner, Ganesh S. Palapattu, Marc A. Dall'Era
ObjectiveTo assess the distribution of key mutations across tumour sizes in clear‐cell renal cell carcinoma (ccRCC), and secondarily to examine the prognostic impact of aggressive mutations in smaller ccRCCs.Patient and MethodsThe distribution of mutations (VHL, PBRM1, SETD2, BAP1 and CDKN2A loss) across tumour sizes was assessed in 1039 ccRCCs treated with nephrectomy in cohorts obtained from the
-
Robot‐assisted nephroureterectomy: surgical and mid‐term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group) BJU Int. (IF 3.7) Pub Date : 2024-09-12 Francesco Ditonno, Antonio Franco, Zhenjie Wu, Linhui Wang, Firas Abdollah, Giuseppe Simone, Andres F. Correa, Matteo Ferro, Sisto Perdonà, Daniele Amparore, Raj Bhanvadia, Stephan Brönimann, Dhruv Puri, Dinno F. Mendiola, Reuben Ben‐David, Sol C. Moon, Courtney Yong, Farshad S. Moghaddam, Alireza Ghoreifi, Eugenio Bologna, Leslie Claire Licari, Marco Finati, Gabriele Tuderti, Emma Helstrom, Marco
ObjectiveTo analyse surgical, functional, and mid‐term oncological outcomes of robot‐assisted nephroureterectomy (RANU) in a contemporary large multi‐institutional setting.Patients and MethodsData were retrieved from the ROBotic surgery for Upper tract Urothelial cancer STtudy (ROBUUST) 2.0 database, an international, multicentre registry encompassing data of patients with upper urinary tract urothelial
-
A decade long insight into patient views on kidney cancer care delivery BJU Int. (IF 3.7) Pub Date : 2024-09-12 Sabrina H. Rossi, Geraldine Fox, Malcolm Packer, Andrew Greaves, Maxine Tran, Natalie Charnley, Grenville Oades, Ekaterini Boleti, Grant D. Stewart
Patient and public involvement and engagement (PPIE) is crucial to ensure that patient care and research is relevant to patient needs and is more likely to have a positive impact. Indeed, previous research priority setting initiatives in kidney cancer, which have led to tangible research programmes, have actively involved patients and their carers [1]. A continued focus on the patients and the public
-
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics BJU Int. (IF 3.7) Pub Date : 2024-09-12 Matthew J. Roberts, Nathan Papa, Hans Veerman, Katelijne de Bie, Andrew Morton, Anthony Franklin, Sheliyan Raveenthiran, William J. Yaxley, Maarten L. Donswijk, Henk G. van der Poel, Hemamali Samaratunga, David Wong, Nicholas Brown, Robert Parkinson, Troy Gianduzzo, Boon Kua, Geoffrey D. Coughlin, Daniela E. Oprea‐Lager, Louise Emmett, Pim J. van Leeuwen, John W. Yaxley, André N. Vis
ObjectivesTo construct and externally calibrate a predictive model for early biochemical recurrence (BCR) after radical prostatectomy (RP) incorporating clinical and modern imaging characteristics of the primary tumour.Patients and MethodsPatients who underwent RP following multiparametric magnetic resonance imaging, prostate biopsy and prostate‐specific membrane antigen‐positron emission tomography/computed
-
Cardiopulmonary exercise testing prior to radical cystectomy: a systematic review and meta‐analysis BJU Int. (IF 3.7) Pub Date : 2024-09-11 Allen Ao Guo, Kieran Zeng, Ymer Bushati, Paul Kim, Wenjie Zhong, Venu Chalasani, Matthew Winter
ObjectiveTo identify the association between cardiopulmonary exercise testing (CPET) and outcomes of radical cystectomy (RC), as RC is historically associated with high rates of short‐ and long‐term morbidity and mortality.MethodsThis quantitative systematic review and meta‐analysis was conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta‐Analysis guidelines. An
-
The potential benefits of concomitant statins treatment in patients with non‐muscle‐invasive bladder cancer BJU Int. (IF 3.7) Pub Date : 2024-09-11 Kang Liu, Rossella Nicoletti, Hongda Zhao, Xuan Chen, Peter Ka‐Fung Chiu, Chi‐Fai Ng, Renate Pichler, Laura S. Mertens, Takafumi Yanagisawa, Luca Afferi, Andrea Mari, Satoshi Katayama, Juan Gomez Rivas, Riccardo Campi, Maria Carmen Mir, Michael Rink, Yair Lotan, Morgan Rouprêt, Shahrokh F. Shariat, Jeremy Yuen‐Chun Teoh
ObjectiveTo investigate the influence of statins on the survival outcomes of patients with non‐muscle‐invasive bladder cancer (NMIBC) treated with adjuvant intravesical bacille Calmette‐Guérin (BCG) immunotherapy.Patients and MethodsA retrospective cohort of consecutive patients with NMIBC who received intravesical BCG therapy from 2001 to 2020 and statins prescription were identified. Overall survival
-
Bridging the knowledge gap: past, present and future of antibiotic use for ureteral stents BJU Int. (IF 3.7) Pub Date : 2024-09-05 Jasper Cornette, Dirk Lange, Ben H. Chew, Thomas Tailly
ObjectiveTo evaluate the available literature on ureteric stent‐related infections, the use of antibiotics and bacterial colonisation to identify the current incidence of stent‐related infections, unveil knowledge gaps and generate potential hypotheses for future research.MethodsA literature review was conducted using PubMed, Cochrane and urological association websites identifying relevant English
-
Robotic appendiceal ureteric interposition or replacement: the surgical technique BJU Int. (IF 3.7) Pub Date : 2024-09-03 Silu Chen, Shubo Fan, Kunlin Yang, Zhihua Li, Wenzhi Gao, Xiang Wang, Zhenyu Li, Bing Wang, Chen Huang, Hongjian Zhu, Yaming Gu, Xuesong Li
-
Contemporary short‐term peri‐operative outcomes of open primary retroperitoneal lymph node dissection BJU Int. (IF 3.7) Pub Date : 2024-09-03 Jacob D. McFadden, Timothy A. Masterson, Clint Cary
ObjectivesTo provide current peri‐operative outcomes and short‐term complication rates for open primary retroperitoneal lymph node dissection (RPLND), with analysis of risk factors for complications.Patients and MethodsUsing the Indiana University Testicular Cancer database, we performed a retrospective analysis of all patients who underwent open primary RPLND over the study period (2018–2021). The
-
Cumulative re‐operation rates during follow‐up after hypospadias repair BJU Int. (IF 3.7) Pub Date : 2024-09-03 Annaleena Anttila, Tuija Lahdes‐Vasama, Niklas Pakkasjärvi, Seppo Taskinen
ObjectiveTo assess the cumulative rates of re‐operations after hypospadias repair and evaluate long‐term surgical outcomes at a tertiary paediatric urology centre.Patients and MethodsRetrospective analysis of 293 boys born between 1991 and 2003 undergoing hypospadias surgery was conducted. The study included 274 patients: 165 with distal, 34 with midshaft, and 75 with proximal hypospadias. Kaplan–Meier
-
Observational study on screen‐detected prostate cancer: case series of empirical clinical practice BJU Int. (IF 3.7) Pub Date : 2024-08-30 Takeshi Takahashi
-
Comparison of perioperative bleeding risk between direct oral anticoagulants in transurethral resection of prostate BJU Int. (IF 3.7) Pub Date : 2024-08-30 Lu Yu Kuo, Jenny Kuo, Joshua Silverman, Jason Jae Yeun Kim, Caitlin Letch, Scott McClintock
ObjectivesTo evaluate the perioperative morbidity and mortality associated with direct oral anticoagulants (DOACs) and warfarin for patients receiving transurethral resection of prostate (TURP).Patients and MethodsThis was a single‐centre, retrospective cohort analysis of patients who underwent TURP for benign prostate hyperplasia from April 2019 to December 2023. The primary objective was to evaluate
-
Variant genital gender‐affirming surgery: a systematic review BJU Int. (IF 3.7) Pub Date : 2024-08-30 Wietse Claeys, Dylan T. Wolff, Alexandra Zachou, Piet Hoebeke, Nicolaas Lumen, Anne‐Françoise Spinoit
ObjectiveTo review the available literature on variant genital gender‐affirming surgery (GGAS), including the reasons for performing it, the surgeries themselves and their outcomes.MethodsA systematic review on the performance of variant GGAS was conducted (International Prospective Register of Systematic Reviews [PROSPERO] identifier: CRD42022306684) researching PubMed, Embase, Web of Science and
-
Varying the intensity of cystoscopic surveillance for high‐risk non‐muscle‐invasive bladder cancer BJU Int. (IF 3.7) Pub Date : 2024-08-30 Zhuo Tony Su, Isabella S. Florissi, Katherine M. Mahon, Taibo Li, Michael E. Rezaee, Nirmish Singla, Sunil H. Patel, Jeffrey P. Townsend, Max R. Kates
ObjectivesTo compare the clinical, economic, and health utility outcomes associated with alternative cystoscopic surveillance regimens for high‐risk non‐muscle‐invasive bladder cancer (HRNMIBC).Patients and MethodsWe performed real‐world clinical data‐driven microsimulations of a hypothetical cohort of 100 000 patients diagnosed with HRNMIBC at age 70 years. The cohort was simulated to undergo alternative
-
Ureteroscopy vs laparoscopic ureterolithotomy: equal treatments? BJU Int. (IF 3.7) Pub Date : 2024-08-29 Øyvind Ulvik
In this issue of the BJUI, Torricelli et al. [1] report results from a randomised trial of participants who underwent treatment for large proximal ureteric stones with flexible ureteroscopy (URS) and holmium:yttrium-aluminium-garnet (Ho:YAG) lithotripsy or retroperitoneal laparoscopic ureterolithotomy (RLU). In total, 64 patients were included and randomised. Stone-free rates (SFRs) were 84.3% for
-
Urinary continence networks in Parkinson's disease: a resting state functional MRI study BJU Int. (IF 3.7) Pub Date : 2024-08-28 Holly A. Roy, Christopher Roy, Heidi Tempest, Alexander L. Green, Ricarda A.L. Menke
Lower urinary tract symptoms (LUTS) are a common feature of Parkinson's disease (PD), affecting up to 70% of patients [1] and significantly impairing quality of life. Ongoing use of continence aids also represents an economic burden. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has been shown to improve LUTS in PD [2] and to have a significant benefit regarding improvement of LUTS
-
Inheritance patterns of lower urinary tract symptoms in adults: a systematic review BJU Int. (IF 3.7) Pub Date : 2024-08-27 Lorcan Moore, Nicholas Raison, Sachin Malde, Prokar Dasgupta, Arun Sahai
ObjectiveTo compile and evaluate the heritability and inheritance patterns of lower urinary tract symptoms (LUTS) in adult cohorts.MethodsSearches of five databases (PubMed, Embase, APA PsycInfo, Global Health, and OVID Medline) commenced on 6 July 2024, resulting in 736 articles retrieved after deduplication. Studies evaluating heritability patterns, gene frequencies, and familial aggregation of symptoms
-
Complete urethral preservation in robot‐assisted radical prostatectomy: step‐by‐step description of surgical technique BJU Int. (IF 3.7) Pub Date : 2024-08-27 Tarek Al‐Hammouri, Ricardo Almeida‐Magana, Lazaros Tzelves, Osama Al‐Bermani, Zafer Tandogdu, Jeremy Ockrim, Greg Shaw
Introduction Robot-assisted radical prostatectomy (RARP) is one of the treatment options for localised clinically significant prostate cancer [1]. However, postoperative urinary incontinence (UI) affects 4–31% of patients 12 months after surgery and is associated with a reduced quality of life [2]. Several surgical strategies have been described to reduce the incidence of UI, including anterior and
-
Outcomes of the Victo™ adjustable artificial urinary sphincter in the treatment of male incontinence BJU Int. (IF 3.7) Pub Date : 2024-08-27 Jan Krhut, Lucie Bartáková, Adéla Kondé, Radek Paus Sýkora, Tomáš Rychlý, Roman Zachoval
ObjectivesTo report the clinical outcomes of the Victo™ (Promedon, Cordoba, Argentina) adjustable artificial urinary sphincter (AUS) implantation in a cohort of patients with severe urinary incontinence (UI) after prostate surgery.Patients and MethodsThis study enrolled patients with UI following prostate surgery who underwent a Victo implantation between May 2018 and December 2023. Patients were prospectively
-
-
-
Utilising the differential renal length index in paediatric pyeloplasty: clinical applications and considerations BJU Int. (IF 3.7) Pub Date : 2024-08-27 Jiayi Li, Weiping Zhang
-
Advances in the detection and treatment of prostate cancer plus d‐mannose for the prevention of recurrent UTIs BJU Int. (IF 3.7) Pub Date : 2024-08-27
-
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer BJU Int. (IF 3.7) Pub Date : 2024-08-27 Muhammad Ali, Young Suk Kwon, Kendrick Koo, Anna Bruynzeel, David Pryor, Daniel G. Schep, Michael Huo, Maggie Stein, Anand Swaminath, Raquibul Hannan, Shankar Siva
ObjectiveTo evaluate the effectiveness and safety of salvage stereotactic ablative body radiotherapy (SABR) for recurrent renal cell carcinoma (RCC) after thermal ablation (TA).Materials and MethodsThis study was a multi‐institutional retrospective analysis of patients with recurrent RCC following TA who received SABR between 2016 and 2020. The primary study outcome was freedom from local failure,
-
Response to utilising the differential renal length index in paediatric pyeloplasty: clinical applications and considerations BJU Int. (IF 3.7) Pub Date : 2024-08-27 Ketaki Gharpure, Abraham Cherian
-
Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer BJU Int. (IF 3.7) Pub Date : 2024-08-26 Jacob I. Taylor, Ashish M. Kamat, Michael A. O'Donnell, Drupad Annapureddy, Jeffrey Howard, Wei Shen Tan, Ian McElree, Facundo Davaro, Kendrick Yim, Stephen Harrington, Elizabeth Dyer, Anna J. Black, Pratik Kanabur, Mathieu Roumiguié, Seth Lerner, Peter C. Black, Jay D. Raman, Mark A. Preston, Gary Steinberg, William Huang, Roger Li, Vignesh T. Packiam, Solomon L Woldu, Yair Lotan
ObjectiveTo quantify the oncological risks of bladder‐sparing therapy (BST) in patients with Bacillus Calmette–Guérin (BCG)‐unresponsive non‐muscle‐invasive bladder cancer (NMIBC) compared to upfront radical cystectomy (RC).Patients and MethodsPre‐specified data elements were collected from retrospective cohorts of patients with BCG‐unresponsive NMIBC from 10 international sites. After Institutional
-
Population-based prostate cancer outcomes registries - what have we learned and where are we heading? BJU Int. (IF 3.7) Pub Date : 2024-08-19 Wee Loon Ong,Krupa Krishnaprasad,Jonathan Bensley,Michelle Steeper,Kerri Beckmann,Sibilah Breen,Michelle King,Stephen Mark,Michael O'Callaghan,Manish Patel,Emma Tod,Jeremy Millar,
-
New diabetic agents providing a glucose feast for urinary yeast - what to do? BJU Int. (IF 3.7) Pub Date : 2024-08-19 Gordon Chen,Andrew A Mahony,Janelle Brennan,Gemma K Reynolds,Victoria G Hall
-
Global viewpoints: proposals for the development of endourology in resource-limited countries in Africa BJU Int. (IF 3.7) Pub Date : 2024-08-12 Saleh Abdelkerim Nedjim, Ouima Justin Dieudonné Ziba, Anteneh Tadesse Kifle, Abdullahi Khalid, Emmanuel Muhawenimana, Tagang Titus Ngwa-Ebogo, Kaleab Habtemichael Gebreselassie, Marcella D. C. Biyouma, Moussa Kalli, Mahamat Ali Mahamat, Mahamane Salissou, Kimassoum Rimtebaye, Choua Ouchemi, Lamine Niang, Berthé Honoré, Noel Coulibaly, James Ndow, John Lazarus, Alain Khassim Ndoye, Mohamed Lezrek, Rachid
Endourology plays an important role in modern urological practice. Compared to open surgery, it offers many advantages. In Africa, endourology is not widely practiced or non-existent in some referral centres. Several factors have been linked to this challenge. This article explores and proposes strategies to improve endourology practice in the African context. Recognising the unique challenges and
-
Surgical cystectomy training using human cadavers embalmed using Thiel's method: a pilot study BJU Int. (IF 3.7) Pub Date : 2024-08-16 Dariya Jaeger, Omar Maghaireh, Andriy Shaleva, Nasreldin Mohammed, Eric Hinrichs, Sven Schumann, Gebhard Reiss, Georg Feigl, Hassan Abol‐Enein, Richard Hautmann
ObjectivesTo develop the use of Thiel soft embalmed human cadavers (TeC) in open radical cystectomy (ORC) training for the first time, to investigate the effect of cadaveric training on surgical trainees' technical skills/performance and to determine how trainees perceive the use of cadaveric workshops.MethodsA 3‐day hands‐on workshop was organised. Ten trainees performed ORC on five TeC, supervised
-
The ‘Prostate Embolisation AS first‐line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial’ (P‐EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH BJU Int. (IF 3.7) Pub Date : 2024-08-14 Nicholas Brown, Anthony Kiosoglous, Stephanie Castree, Sepinoud Firouzmand, Rhiannon McBean, Duncan G. Walker, Sean Wallace, Boon Kua, Troy Gianduzzo, Rachel C. Esler, Peter Campbell, Joseph Schoeman, John Yaxley
ObjectiveTo compare prostate artery embolisation (PAE) to the combination of tamsulosin and dutasteride therapy as a potential first‐line therapy for obstructive benign prostatic hyperplasia (BPH) in treatment‐naïve patients in the ‘Prostate Embolisation AS first‐line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial’ (P‐EASY ADVANCE).Patients
-
British Association of Urological Surgeons (BAUS) consensus document for the management of benign female urethral lesions BJU Int. (IF 3.7) Pub Date : 2024-08-11 Magda Kujawa, Suzanne Biers, Mahreen Pakzad, Arun Sahai, Ased Ali, Tina Rashid, Hashim Hashim, Nadir I. Osman, Andy Kozan, Mo Belal
To provide a consensus document for the management of benign female urethral lesions.
-
Foley catheter after ureteroscopy and JJ stent placement: a randomised prospective European Association of Urology Section of Urolithiasis-Young Academic Urologists (EULIS-YAU) endourology study BJU Int. (IF 3.7) Pub Date : 2024-08-11 Tarik Emre Sener, Gunal Ozgur, Mehmet Cetin, Amelia Pietropaolo, Lazaros Tzelves, Francesco Esperto, Bhaskar Somani, Yiloren Tanidir
To evaluate the effects of inserting a Foley catheter after ureteroscopy (URS) and JJ stent placement on pain scores, voiding patterns, biochemical parameters and postoperative complications.
-
Outcomes after laser enucleation of the prostate with and without significant storage symptoms BJU Int. (IF 3.7) Pub Date : 2024-08-07 Cristina Cano Garcia, Maria Welte, Maximilian Filzmayer, Pia Bongardt, Fiona Schlesinger, Ivan Nikolov, Zhe Tian, Pierre I. Karakiewicz, Luis A. Kluth, Philipp Mandel, Felix K. H. Chun, Marina Kosiba, Andreas Becker
To test for differences in recovery of lower urinary tract symptoms (LUTS) between patients with storage-positive vs -negative symptoms after laser enucleation of the prostate (LEP).
-
Enhancing perioperative pain management: the integrative potential of acupuncture in urological surgery BJU Int. (IF 3.7) Pub Date : 2024-08-07 Fu‐Xiang Lin, Yang Chen, Zhan‐Ping Xu
-
Enhancing perioperative pain management: the integrative potential of acupuncture in urological surgery – authors’ reply BJU Int. (IF 3.7) Pub Date : 2024-08-07 Jean Maurer, Francesca Ambrosini, Thomas Friedemann, Yuelai Chen, Sven Schroeder
-
Human in vivo baseline intrarenal pressure, peristaltic activity and response to ureteric stenting BJU Int. (IF 3.7) Pub Date : 2024-08-06 Stefanie M. Croghan, Eoghan M. Cunnane, Sorcha O’Meara, Connor V. Cunnane, James C. Forde, Rustom P. Manecksha, Michael T. Walsh, Kieran J. Breen, Barry B. McGuire, Fergal J. O’Brien, Niall F. Davis
To assess human in vivo intrarenal pressure (IRP) and peristaltic activity at baseline and after ureteric stent placement, using a narrow calibre pressure guidewire placed retrogradely in the renal pelvis.
-
Differential attainment and factors associated with training applications and outcomes: Urology in the United Kingdom BJU Int. (IF 3.7) Pub Date : 2024-08-05 Martina Spazzapan, Sarika Grover, Siddarth Raj, Beth Russell, Sachin Malde, Stella Vig, Simon Fleming
Urology is the fourth largest surgical specialty in the UK with just under 1000 practicing consultants [1]. Following the 2-year Foundation Programme, doctors wishing to pursue urology training will typically go through two competitive national recruitment processes to enter Core Surgical Training (CST) followed by Higher Surgical Training (HST), starting as a Specialty Trainee Year 3 (ST3). In 2022
-
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation – IRE-IMMUNO study BJU Int. (IF 3.7) Pub Date : 2024-08-05 Bart Geboers, Matthijs J. Scheltema, Jason Jung, Joyce Bakker, Florentine E.F. Timmer, Xanthe Cerutti, Athos Katelaris, Paul Doan, William Gondoputro, Alexandar Blazevski, Shikha Agrawal, Jayne Matthews, Anne-Maree Haynes, Tim Robertson, James E. Thompson, Martijn R. Meijerink, Susan J. Clark, Tanja D. de Gruijl, Phillip D. Stricker
To prospectively compare systemic anti-tumour immune responses induced by irreversible electroporation (IRE) and robot-assisted radical prostatectomy (RARP) in patients with localised intermediate-risk prostate cancer (PCa).
-
National Surgical Quality Improvement Program audit of contemporary perioperative care for radical cystectomy BJU Int. (IF 3.7) Pub Date : 2024-08-01 John Pfail, Jasmin Capellan, Rachel Passarelli, Alain Kaldany, Kevin Chua, Benjamin Lichtbroun, Arnav Srivastava, David Golombos, Thomas L. Jang, Henry A. Pitt, Vignesh T. Packiam, Saum Ghodoussipour
ObjectiveTo examine the impact of increased compliance to contemporary perioperative care measures, as outlined by enhanced recover after surgery (ERAS) guidelines, among patients undergoing radical cystectomy (RC).Patients and MethodsFrom the National Surgical Quality Improvement Program database we captured patients undergoing RC between 2019 and 2021. We identified five perioperative care measures:
-
Ureteroscopy vs laparoscopic ureterolithotomy for large proximal ureteric stone: a randomised trial BJU Int. (IF 3.7) Pub Date : 2024-07-31 Fabio C. M. Torricelli, Victor Srougi, Giovanni S. Marchini, Fabio C. Vicentini, Carlos A. Batagello, Alexandre Danilovic, Marco A. Arap, Hiury Andrade, Anuar I. Mitre, Ricardo D. Jordão, Manoj Monga, William C. Nahas, Eduardo Mazzucchi
ObjectiveTo compare the outcomes of retrograde flexible ureteroscopy (fURS) with retroperitoneal laparoscopic ureterolithotomy (RLU) for large proximal ureteric stones.Patients and MethodsA prospective randomised trial was conducted from January 2018 through December 2022 including patients with impacted proximal ureteric stones of 15–25 mm. Patients underwent fURS or RLU. Primary outcome was the stone‐free
-
Prognostic role of the neutrophil/lymphocyte ratio in high‐risk BCG‐naïve non‐muscle‐invasive bladder cancer treated with intravesical gemcitabine/docetaxel BJU Int. (IF 3.7) Pub Date : 2024-07-31 Mohamad Abou Chakra, Riitta Lassila, Nancy El Beayni, Sarah L. Mott, Michael A. O'Donnell
ObjectivesTo investigate the role of pretreatment neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio (PLR) in the prediction of response to sequential intravesical therapy, gemcitabine and docetaxel (Gem/Doce), given to patients with bacille Calmette–Guérin (BCG)‐ naïve high‐risk non‐muscle‐invasive bladder cancer (NMIBC).Patients and MethodsA retrospective analysis was conducted
-
Innovation, development and clinical adoption of ureteroscopy: a time trend since its first inception BJU Int. (IF 3.7) Pub Date : 2024-07-31 Ali Talyshinskii, B. M. Zeeshan Hameed, Nithesh Naik, Patrick Juliebø‐Jones, Bhaskar Kumar Somani
-
Classification systems for chronic pelvic pain in males: a systematic review BJU Int. (IF 3.7) Pub Date : 2024-07-30 Marie‐Pierre Cyr, Irmina Nahon, Rachel Worman, David Cowley, Paul W. Hodges
ObjectiveTo systematically review the classification systems for male chronic pelvic pain (CPP).MethodsThe Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica dataBASE (EMBASE), and Web of Science were searched. Any publication, with no restriction to publication date, was eligible. Publications had to propose a classification system for CPP in males or provide additional
-
Response to BJU-2024-0780: RE: The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers. BJU Int. (IF 3.7) Pub Date : 2024-07-26 Elizabeth K Bancroft,
-
RE: ‘The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers’ BJU Int. (IF 3.7) Pub Date : 2024-07-26 Hinpetch Daungsupawong, Viroj Wiwanitkit
-
‘Case of the Month’ from Imperial College Hospitals, London, UK: pulmonary embolectomy following embolism during caval tumour thrombus nephrectomy for renal cell carcinoma BJU Int. (IF 3.7) Pub Date : 2024-07-26 Theodore Birks, Archie Hughes‐Hallett, Walter Cazzaniga, Antanas Macys, Alessandro Viviano, Faiz Mumtaz, David Nicol
-
Predictors for selection of outpatient single‐port robot‐assisted laparoscopic radical prostatectomy BJU Int. (IF 3.7) Pub Date : 2024-07-25 Nicolas A. Soputro, Roxana Ramos‐Carpinteyro, Jaya S. Chavali, Adriana M. Pedraza, Carter D. Mikesell, Jihad Kaouk
ObjectiveTo evaluate the different perioperative variables that may serve as important clinical predictors when selecting patients for outpatient single‐port robot‐assisted radical prostatectomy (SP‐RARP).Patients and MethodsA retrospective review was performed on the Institutional Review Board‐approved, prospectively maintained database to identify 485 consecutive patients who underwent SP‐RARP between
-
The carbon footprint of the perioperative transurethral resection of bladder tumour pathway BJU Int. (IF 3.7) Pub Date : 2024-07-25 Joseph B. John, Michael Collins, Sophie Eames, Kieran O’Flynn, Tim W.R. Briggs, William K. Gray, John S. McGrath
ObjectivesTo evaluate the carbon footprint of the perioperative transurethral resection of bladder tumour (TURBT) pathway from decision to treat to postoperative discharge, and model potential greenhouse gas (GHG) emissions reduction strategies.Materials and MethodsThis process‐based attributional cradle‐to‐grave life‐cycle assessment (LCA) of GHG emissions modelled the perioperative TURBT pathway
-
Conservative interventions for female exercise‐induced urinary incontinence: a systematic review BJU Int. (IF 3.7) Pub Date : 2024-07-24 Marina Petter Rodrigues, Marie‐Ève Bérubé, Marylène Charette, Linda McLean
ObjectiveTo systematically review and synthesise what is known about the effectiveness of non‐pharmaceutical conservative interventions for the management of urinary incontinence (UI) experienced by women during physical exercise.MethodsA systematic search was performed in the following databases in September 2023: the Medical Literature Analysis and Retrieval System Online (MEDLINE), Cumulative Index
-
Pseudoephedrine for ejaculatory dysfunction after retroperitoneal lymph node dissection in testicular cancer BJU Int. (IF 3.7) Pub Date : 2024-07-24 Ciara Conduit, Jeremy Lewin, Wei Hong, Ie‐Wen Sim, Gulfam Ahmad, Matt Leonard, Sophie O'Haire, Mary Moody, Amanda D. Hutchinson, Nathan Lawrentschuk, Benjamin Thomas, Haryana M. Dhillon, Ben Tran
ObjectiveTo assess the impact of ejaculatory dysfunction (EjD; failure of emission or retrograde ejaculation) on health‐related quality of life (HRQoL) after retroperitoneal lymph node dissection (RPLND) for testicular cancer and explore the efficacy of pseudoephedrine hydrochloride as treatment.Patients and MethodsIn a single arm, phase II trial, patients at ≥6 months after RPLND were invited to complete
-
A randomised trial of short‐ vs long‐term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06‐24 BJU Int. (IF 3.7) Pub Date : 2024-07-23 Carmen González‐San Segundo, Fernando López Campos, Alfonso Gómez Iturriaga, Aurora Rodríguez, Jesús Olivera, Víctor Duque‐Santana, Gemma Sancho, Iván Henríquez, Antonio José Conde, Jeannette Valero, Xavier Maldonado, Luis Glaria, Begoña Caballero, Noelia Sanmamed, Joel Mases, Anna María Boladeras‐Inglada, Miguel Montijano, Marina Santos, Ana Álvarez, Juan I. Martínez, Felipe Couñago
BackgroundSalvage radiotherapy (SRT) and androgen‐deprivation therapy (ADT) are widely used in routine clinical practice to treat patients with prostate cancer who develop biochemical recurrence (BCR) after radical prostatectomy (RP). However, there is no standard‐of‐care consensus on optimal duration ADT. Investigators propose three distinct risk groups in patients with prostate cancer treated with
-
‘Case of the Month’ from the Western General Hospital, Edinburgh, UK: invasive vesical Candida infection causing ureteric obstruction in a female diabetic patient BJU Int. (IF 3.7) Pub Date : 2024-07-23 Jamie V. Krishnan, Marie O’Donnell, Alexander Laird
-
Identifying the facilitators and barriers to implementation of renal tumour biopsy in the diagnostic pathway for small renal masses BJU Int. (IF 3.7) Pub Date : 2024-07-23 Veronica Ranieri, Hannah Warren, Isabella Florez, Joana B. Neves, Miles Walkden, Darryl E. Bernstein, Joseph Santiapillai, Norman Williams, William H. Wildgoose, Prasad Patki, Grant D. Stewart, Netty Kinsella, Elena Pizzo, Ravi Barod, Axel Bex, Faiz Mumtaz, Soha El‐Sheikh, Kurinchi Gurusamy, Maxine G.B. Tran
ObjectivesTo understand the facilitators and barriers to the implementation of renal tumour biopsy (RTB) in the diagnostic pathway for renal tumours in England.Patients and MethodsParticipants consisted of patients who had a renal tumour diagnosed and/or treated at one of five tertiary centres in England, healthcare professionals involved in the direct care of patients diagnosed with renal tumours
-
‘Supported-at-Home’ video tuition of the trial dose of intracavernosal alprostadil BJU Int. (IF 3.7) Pub Date : 2024-07-16 Findlay MacAskill, Piotr Śluzar, Patrick Gordon, Karen Briggs, Amy Sandher, Tet Yap, Sarah Hewson, Emma Barron, Arun Sahai, Ian Eardley, Majed Shabbir
Intracavernosal injections (ICIs) are important in the management of erectile dysfunction (ED) following failure of phosphodiesterase type 5 inhibitors (PDE5i) or in patients after a non-nerve-sparing robot-assisted radical prostatectomy (RARP). The first injection is traditionally taught in a face-to-face consultation [1], and the British National Formulary states that the first dose must be given
-
Prospective study of urinary incontinence recovery following endoscopic enucleation of the prostate BJU Int. (IF 3.7) Pub Date : 2024-07-19 Shao‐Wei Wu, Chi‐Shin Tseng, Lun‐Hsiang Yuan, Yu‐Wen Huang, Yi‐Jhou Chen, Ming‐Chieh Kuo, Jeff Shih‐Chieh Chueh, Shi‐Wei Huang
ObjectiveTo investigate the clinical trajectories and identify risk factors linked to post‐enucleation urinary incontinence (UI).Patients and MethodsIn this prospective study (April 2020 to March 2022) at a single institution, 316 consecutive patients receiving endoscopic enucleation due to benign prostatic enlargement were included. Patient information and perioperative details were collected. Follow‐ups
-
Penile intraepithelial neoplasia incidence, clinical classification, microenvironment and implications for imiquimod treatment BJU Int. (IF 3.7) Pub Date : 2024-07-19 Ofir Avitan, Tynisha Rafael, Manon Vreeburg, Laura Elst, Elise M. Bekers, Maarten Albersen, Ekaterina S. Jordanova, Oscar Brouwer
ObjectivesTo provide an outline of the existing data on penile intraepithelial neoplasia (PeIN), as well as a narrative review on imiquimod (IQ; a toll‐like receptor 7 agonist) treatment and immune microenvironment markers that may predict response to treatment.MethodsA narrative review of the literature from 2000 to the present was conducted on PubMed, and we describe the most relevant data and cross
-
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer BJU Int. (IF 3.7) Pub Date : 2024-07-18 Jie Yang, Xingyu Xiong, Qiang Wei, Lu Yang